2D QSAR studies on a series of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one as CETP inhibitors

References

• A. Garcia-Rios, J.F. Alcala-Diaz, F. Gomez-Delgado, J. Delgado-Lista, C. Marin, A. Leon-Acuña, A. Camargo, F. Rodriguez-Cantalejo, R. Blanco-Rojo, and G. Quintana-Navarro, Beneficial effect of CETP gene polymorphism in combination with a mediterranean diet influencing lipid metabolism in metabolic syndrome patients: CORDIOPREV study, Clin. Nutr. 37 (2018), pp. 229–234. doi:10.1016/j.clnu.2016.12.011.
   PubMed Web of Science ®Google Scholar
• G.J. de Grooth, A.H. Klerkx, E.S. Stroes, A.F. Stalenhoef, J.J. Kastelein, and J.A. Kuivenhoven, A review of CETP and its relation to atherosclerosis, J. Lipid Res. 45 (2004), pp. 1967–1974. doi:10.1194/jlr.R400007-JLR200.
   PubMed Web of Science ®Google Scholar
• P. Linsel-Nitschke and A.R. Tall, HDL as a target in the treatment of atherosclerotic cardiovascular disease, Nat. Rev. Drug Discov. 4 (2005), pp. 193–205. doi:10.1038/nrd1658.
   PubMed Web of Science ®Google Scholar
• C. Baigent, A. Keech, P. Kearney, R. Collins, and J. Simes, Efficacy and safety of cholesterol-lowering treatment–Authors’ reply, Lancet 367 (2006), pp. 470–471. doi:10.1016/S0140-6736(06)68171-3.
   Web of Science ®Google Scholar
• M. Law and N.J. Wald, Efficacy and safety of cholesterol-lowering treatment, Lancet 367 (2006), pp. 469–470. doi:10.1016/S0140-6736(06)68170-1.
   PubMed Web of Science ®Google Scholar
• B.G. Brown, K.H. Stukovsky, and X.-Q. Zhao, Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: A meta-analysis of 23 randomized lipid trials, Curr. Opin. Lipidol. 17 (2006), pp. 631–636. doi:10.1097/MOL.0b013e32800ff750.
   PubMed Web of Science ®Google Scholar
• I.M. Singh, M.H. Shishehbor, and B.J. Ansell, High-density lipoprotein as a therapeutic target: A systematic review, Jama 298 (2007), pp. 786–798. doi:10.1001/jama.298.7.786.
   PubMed Web of Science ®Google Scholar
• R.S. Barkowski and W.H. Frishman, HDL metabolism and CETP inhibition, Cardiol. Rev. 16 (2008), pp. 154–162. doi:10.1097/CRD.0b013e31816a3b60.
   PubMed Web of Science ®Google Scholar
• R. Dullaart, G. Dallinga‐Thie, B. Wolffenbuttel, and A. Van Tol, CETP inhibition in cardiovascular risk management: A critical appraisal, Eur. J. Clin. Invest. 37 (2007), pp. 90–98. doi:10.1111/j.1365-2362.2007.01756.x.
   PubMed Web of Science ®Google Scholar
• A.H. Klerkx, K.E. Harchaoui, W.A. van der Steeg, S.M. Boekholdt, E.S. Stroes, J.J. Kastelein, and J.A. Kuivenhoven, Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: Pathways by which modulation of CETP activity may alter atherogenesis, Arterioscler. Thromb. Vasc. Biol. 26 (2006), pp. 706–715. doi:10.1161/01.ATV.0000205595.19612.c9.
   PubMed Web of Science ®Google Scholar
• P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.-C. Tardif, and D.D. Waters, Effects of torcetrapib in patients at high risk for coronary events, N. Engl. J. Med. 357 (2007), pp. 2109–2122. doi:10.1056/NEJMoa0706628.
   PubMed Web of Science ®Google Scholar
• S.E. Nissen, J.-C. Tardif, S.J. Nicholls, J.H. Revkin, C.L. Shear, W.T. Duggan, W. Ruzyllo, W.B. Bachinsky, G.P. Lasala, and E.M. Tuzcu, Effect of torcetrapib on the progression of coronary atherosclerosis, N. Engl. J. Med. 356 (2007), pp. 1304–1316. doi:10.1056/NEJMoa070635.
   PubMed Web of Science ®Google Scholar
• A. Ali, Z. Lu, P.J. Sinclair, G.E. Taylor, C.F. Thompson, C.J. Smith, A.A. Dowst, and Y.-H. Chen, CETP Inhibitors, U.S. Patent No. 7,781,426. Washington, DC: U.S. Patent and Trademark Office, 2010.
   Google Scholar
• C.P. Cannon, H.M. Dansky, M. Davidson, A.M. Gotto Jr, E.A. Brinton, A.L. Gould, M. Stepanavage, S.X. Liu, S. Shah, and J. Rubino, Design of the define trial: Determining the efficacy and tolerability of CETP inhibition with anacetrapib, Am. Heart J. 158 (2009), pp. 513–519. e3. doi:10.1016/j.ahj.2009.07.028.
   PubMed Web of Science ®Google Scholar
• C.P. Cannon, S. Shah, H.M. Dansky, M. Davidson, E.A. Brinton, A.M. Gotto Jr, M. Stepanavage, S.X. Liu, P. Gibbons, and T.B. Ashraf, Safety of anacetrapib in patients with or at high risk for coronary heart disease, N. Engl. J. Med. 363 (2010), pp. 2406–2415. doi:10.1056/NEJMoa1009744.
   PubMed Web of Science ®Google Scholar
• D. Gutstein, R. Krishna, D. Johns, H. Surks, H. Dansky, S. Shah, Y. Mitchel, J. Arena, and J. Wagner, Anacetrapib, a novel CETP inhibitor: Pursuing a new approach to cardiovascular risk reduction, Clin. Pharmacol. Ther. 91 (2012), pp. 109–122. doi:10.1038/clpt.2011.271.
   PubMed Web of Science ®Google Scholar
• M.A. Kelkar, D.V. Pednekar, S.R. Pimple, and K.G. Akamanchi, 3D QSAR studies of inhibitors of cholesterol ester transfer protein (CETP) by CoMFA, CoMSIA and GFA methodologies, Med. Chem. Res. 13 (2004), pp. 590–604. doi:10.1007/s00044-004-0104-9.
   Web of Science ®Google Scholar
• P. Hanumantharao, S. Sambasivarao, L. Soni, A. Gupta, and S. Kaskhedikar, QSAR analysis of analogs of bis [2-(acylamino) phenyl] disulfides, 2-(acylamino) benzenethiols and S-[2-(acylamino) phenyl] alkanethioates as antihyperlipidemic agents, Indian J. Chem. B 44 (2005), pp. 1481–1486.
   Google Scholar
• M.S. Castilho, R.V. Guido, and A.D. Andricopulo, 2D quantitative structure–activity relationship studies on a series of cholesteryl ester transfer protein inhibitors, Bioorg. Med. Chem. 15 (2007), pp. 6242–6252. doi:10.1016/j.bmc.2007.06.021.
   PubMed Web of Science ®Google Scholar
• S. Riahi, E. Pourbasheer, M.R. Ganjali, and P. Norouzi, Support vector machine‐based quantitative structure–activity relationship study of cholesteryl ester transfer protein inhibitors, Chem. Biol. Drug Des. 73 (2009), pp. 558–571. doi:10.1111/j.1747-0285.2009.00800.x.
   PubMed Web of Science ®Google Scholar
• M. Asadollahi-Baboli, Docking and receptor-based QSAR approaches for modeling of CETP inhibitors, Med. Chem. Res. 23 (2014), pp. 1162–1169. doi:10.1007/s00044-013-0722-1.
   Web of Science ®Google Scholar
• R. Abu Khalaf, S. Al-Rawashdeh, D. Sabbah, and G. Abu Sheikha, Molecular docking and pharmacophore modeling studies of fluorinated benzamides as potential CETP inhibitors, Med. Chem. 13 (2017), pp. 239–253. doi:10.2174/1573406412666161104121042.
   PubMed Web of Science ®Google Scholar
• T. Äijänen, A. Koivuniemi, M. Javanainen, S. Rissanen, T. Rog, and I. Vattulainen. How anacetrapib inhibits the activity of the cholesteryl ester transfer protein? Perspective through atomistic simulations. PLoS Comput. Biol. 10 (2014), e1003987. doi:10.1371/journal.pcbi.1003987
   PubMed Web of Science ®Google Scholar
• M. Jamalan, M. Zeinali, and M.A. Ghaffari, A molecular dynamics investigation on the inhibition mechanism of cholesteryl ester transfer protein by anacetrapib, Med. Chem. Res. 25 (2016), pp. 62–69. doi:10.1007/s00044-015-1471-0.
   Web of Science ®Google Scholar
• OECD. Guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models. Organisation for Economic Co-operation and Development, Paris, France, 2007.
   Google Scholar
• X. Chen, M. Liu, and M.K. Gilson, BindingDB: A web-accessible molecular recognition database, Comb. Chem. High Throughput Screen. 4 (2001), pp. 719–725. doi:10.2174/1386207013330670.
   PubMed Web of Science ®Google Scholar
• P. Labute, Molecular Operating Environment. Chemical Computing Group, Inc., Canada, Montreal, 2008.
   Google Scholar
• C.W. Yap, PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints, J. Comput. Chem. 32 (2011), pp. 1466–1474. doi:10.1002/jcc.21707.
   PubMed Web of Science ®Google Scholar
• S. Bitam, M. Hamadache, and S. Hanini, QSAR model for prediction of the therapeutic potency of N-benzylpiperidine derivatives as AChE inhibitors, SAR QSAR Environ. Res 28 (2017), pp. 471–489. doi:10.1080/1062936X.2017.1331467.
   PubMed Web of Science ®Google Scholar
• M. Hamadache, S. Hanini, O. Benkortbi, A. Amrane, L. Khaouane, and C.S. Moussa, Artificial neural network-based equation to predict the toxicity of herbicides on rats, Chemom. Intell. Lab. Syst. 154 (2016), pp. 7–15. doi:10.1016/j.chemolab.2016.03.007.
   Web of Science ®Google Scholar
• D.B. De Oliveira and A.C. Gaudio, BuildQSAR: A new computer program for QSAR analysis, Quant. Struct. Act. Relat. 19 (2000), pp. 599–601. doi:10.1002/1521-3838(200012)19:6<599::AID-QSAR599>3.0.CO;2-B.
   Google Scholar
• C. Yap, H. Li, Z. Ji, and Y. Chen, Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological properties, Mini-Rev. Med. Chem. 7 (2007), pp. 1097–1107. doi:10.2174/138955707782331696.
   PubMed Web of Science ®Google Scholar
• G. Snedecor and W. Cochran, Statistical Methods 6th Edition, The Iowa State University Press, Ames, 1967.
   Google Scholar
• C.J.C. Burges, A tutorial on support vector machines for pattern recognition, Data Mining Knowledge Discov. 10 (2014), pp. 121–167. doi:10.1023/A:1009715923555.
   Web of Science ®Google Scholar
• V. Vapnik, Estimation of Dependences Based on Empirical Data, Springer Science & Business Media, New York, 2006.
   Google Scholar
• J.C. Boot, Quadratic Programming: Algorithms, Anomalies, Applications, in Studies in Mathematical and Managerial Economics, Vol. 2. North Holland Publishing Company, Amsterdam, 1964.
   Google Scholar
• B.E. Boser, I.M. Guyon, and V.N. Vapnik, A training algorithm for optimal margin classifiers, Proceedings of the Fifth Annual Workshop on Computational Learning Theory - COLT ’92, Pittsburgh Pennsylvania, USA, 1992.
   Google Scholar
• V. Vapnik, The Nature of Statistical Learning Theory, Springer Science & Business Media, New York, 2013.
   Google Scholar
• R. Mendes, P. Cortez, M. Rocha, and J. Neves, Particle swarms for feedforward neural network training, Proceedings of the 2002 International Joint Conference on Neural Networks. IJCNN’02, (Cat. No. 02CH37290), Honolulu, HI, USA, 2002, pp. 1895–1899 vol. 2, doi:10.1109/IJCNN.2002.1007808. 2002.
   Google Scholar
• S. Mirjalili, Evolutionary Feedforward Neural Networks, in Evolutionary Algorithms and Neural Networks, Springer, New York, 2019, pp. 75–86.
   Google Scholar
• J. Kennedy and R. Eberhart, Particle Swarm optimization, International Conference on Neural Networks, Perth, WA, Australia, 1995, pp. 1942–1948 vol. 4, doi:10.1109/ICNN.1995.488968. 1995.
   Google Scholar
• R. Eberhart and J. Kennedy, A new optimizer using particle swarm theory, MHS’95. Proceedings of the Sixth International Symposium on Micro Machine and Human Science, Nagoya, Japan, 1995, pp. 39–43, doi:10.1109/MHS.1995.494215. 1995.
   Google Scholar
• R. Eberhart, P. Simpson, and R. Dobbins, Computational Intelligence PC Tools, Academic Press Professional, Inc., Boston, 1996.
   Google Scholar
• M. Meer, M. Schmuker, and G. Schneider, Optimized particle swarm optimization (OPSO) and its application to artificial neural network training, BMC Bioinform. 7 (2006), pp. 125. doi:10.1186/1471-2105-7-125.
   PubMed Web of Science ®Google Scholar
• C. Zhang, H. Shao, and Y. Li, Particle swarm optimisation for evolving artificial neural network. SMC 2000 Conference Proceedings. 2000 IEEE International Conference on Systems, Man and Cybernetics. Cybernetics Evolving to Systems, Humans, Organizations, and Their Complex Interactions, Cat. no. 0, Nashville, TN, 2000, pp. 2487–2490 vol. 4, doi:10.1109/ICSMC.2000.884366. 2000.
   Google Scholar
• S. Mirjalili, S.Z.M. Hashim, and H.M. Sardroudi, Training feedforward neural networks using hybrid particle swarm optimization and gravitational search algorithm, Appl. Math Comput. 218 (2012), pp. 11125–11137.
   Web of Science ®Google Scholar
• M.N. Alam, B. Das, and V. Pant, A comparative study of metaheuristic optimization approaches for directional overcurrent relays coordination, Electr. Pow. Syst. Res. 128 (2015), pp. 39–52. doi:10.1016/j.epsr.2015.06.018.
   Web of Science ®Google Scholar
• Q. Bai, Analysis of particle swarm optimization algorithm, Comput. Inf. Sci. 3 (2010), pp. 180.
   Google Scholar
• Y. Shi and R. Eberhart, A modified particle swarm optimizer. 1998 IEEE International Conference on Evolutionary Computation Proceedings. IEEE World Congress on Computational Intelligence, (Cat. No. 98TH8360), Anchorage, AK, USA, 1998, pp. 69–73, doi:10.1109/ICEC.1998.699146. 1998.
   Google Scholar
• J. Kennedy, The particle swarm: Social adaptation of knowledge, Proceedings of 1997 IEEE International Conference on Evolutionary Computation (ICEC ’97), Indianapolis, IN, USA, 1997, pp. 303–308, doi:10.1109/ICEC.1997.592326.
   Google Scholar
• M.N. Alam, Codes in Matlab for Particle Swarm Optimization, Research Gate Indian, Institute of Technology Roorkee, 2016. doi:10.13140/RG.2.1.1078.7608.
   Google Scholar
• M. Alam, Codes in MATLAB for training artificial neural network using particle swarm optimization, Research Gate (2016), pp. 1–16. doi:10.13140/RG.2.1.2579.3524.
   Google Scholar
• P.K. Ojha, I. Mitra, R.N. Das, and K. Roy, Further exploring r m 2 metrics for validation of QSPR models, Chemom. Intell. Lab. Syst. 107 (2011), pp. 194–205. doi:10.1016/j.chemolab.2011.03.011.
   Web of Science ®Google Scholar
• G. Schüürmann, R.-U. Ebert, J. Chen, B. Wang, and R. Kühne, External validation and prediction employing the predictive squared correlation coefficient. Test set activity mean vs training set activity mean, J. Chem. Inf. Model. 48 (2008), pp. 2140–2145. doi:10.1021/ci800253u.
   PubMed Web of Science ®Google Scholar
• I. Lawrence and K. Lin, A concordance correlation coefficient to evaluate reproducibility, Biometrics 45 (1989), pp. 255–268.
   PubMed Web of Science ®Google Scholar
• N. Chirico and P. Gramatica, Real external predictivity of QSAR models: How to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient, J. Chem. Inf. Model. 51 (2011), pp. 2320–2335. doi:10.1021/ci200211n.
   PubMed Web of Science ®Google Scholar
• S. Bitam, M. Hamadache, and S. Hanini, Prediction of therapeutic potency of tacrine derivatives as BuChE inhibitors from quantitative structure–activity relationship modelling, SAR QSAR Environ. Res. 29 (2018), pp. 213–230. doi:10.1080/1062936X.2018.1423640.
   PubMed Web of Science ®Google Scholar
• K. Roy, P. Ambure, and R.B. Aher, How important is to detect systematic error in predictions and understand statistical applicability domain of QSAR models? Chemom. Intell. Lab. Syst. 162 (2017), pp. 44–54. doi:10.1016/j.chemolab.2017.01.010.
   Web of Science ®Google Scholar